Karaca, B. Et Al. 2021. Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ER alpha and Wnt/beta-catenin signaling pathways. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.35, no.11 .

Karaca, B., Bakır, E., Yerer, M. B., Cumaoğlu, A., Hamurcu, Z., & Eken, A., (2021). Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ER alpha and Wnt/beta-catenin signaling pathways. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.35, no.11.

Karaca, Busra Et Al. "Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ER alpha and Wnt/beta-catenin signaling pathways," JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.35, no.11, 2021

Karaca, Busra Et Al. "Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ER alpha and Wnt/beta-catenin signaling pathways." JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.35, no.11, 2021

Karaca, B. Et Al. (2021) . "Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ER alpha and Wnt/beta-catenin signaling pathways." JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.35, no.11.

@article{article, author={Busra Karaca Et Al. }, title={Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ER alpha and Wnt/beta-catenin signaling pathways}, journal={JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY}, year=2021}